Repolarization effects of sertindole manifest as T-wave flatness on the ECG

Flattening of the electrocardiographic T-wave has been associated with proarrhythmic risk. It has also been demonstrated that triangulation of the monophasic action potential (MAP) manifests on the ECG as a flattened T-wave. In this study we investigate the effects of sertindole on the electrocardiographic T-wave using a recently developed ECG marker of T-wave flatness which is directly correlated with sertindole-induced triangulation of the MAP prior to Torsade de Pointes arrhythmia in dogs. The effect of sertindole on T-wave flatness was compared with the effects of moxifloxacin and placebo on the T-wave. Sertindole caused more flattening of the T-wave compared to moxifloxacin and placebo. Effect sizes also revealed that flattening of the T-wave after sertindole was a more prominent finding compared to QT interval prolongation. An electrocardiographic measurement linking MAP triangulation and T-wave flatness could potentially used for cardiac safety assessment in drug trials along with other safety measures.

[1]  A J Camm,et al.  Evaluation of Drug-Induced QT Interval Prolongation , 2001, Drug safety.

[2]  Johannes J. Struijk,et al.  Flattening of the electrocardiographic T-wave is a sign of proarrhythmic risk and a reflection of action potential triangulation , 2013, Computing in Cardiology 2013.

[3]  Johannes J. Struijk,et al.  Sertindole causes distinct electrocardiographic T-wave morphology changes , 2009, European Neuropsychopharmacology.

[4]  J. Ruskin,et al.  Drug‐Induced Torsades de Pointes and Implications for Drug Development , 2004, Journal of cardiovascular electrophysiology.

[5]  Jørgen K. Kanters,et al.  Quantitative Analysis of T‐wave Morphology Increases Confidence in Drug‐Induced Cardiac Repolarization Abnormalities: Evidence From the Investigational IKr Inhibitor Lu 35–138 , 2009, Journal of clinical pharmacology.

[6]  Wojciech Zareba,et al.  T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition. , 2011, Heart rhythm.

[7]  G. Duker,et al.  Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic , 2001, Circulation.

[8]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[9]  Jørgen K. Kanters,et al.  Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics , 2011, CNS drugs.

[10]  G. Breithardt,et al.  Proarrhythmia as a Class Effect of Quinolones: Increased Dispersion of Repolarization and Triangulation of Action Potential Predict Torsades de Pointes , 2007, Journal of cardiovascular electrophysiology.

[11]  Borje Darpo,et al.  ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs , 2005 .

[12]  Michael Christiansen,et al.  Identifying Drug-Induced Repolarization Abnormalities from Distinct ECG Patterns in Congenital Long QT Syndrome , 2009, Drug safety.

[13]  F. Younas,et al.  Moxifloxacin-Induced QT Prolongation and Torsades: An Uncommon Effect of a Common Drug , 2009, The American journal of the medical sciences.